About Altis Biosystems
Altis Biosystems is a Healthcare company based in Durham (United States) founded in 2015 by Scott Magness, Nancy Allbritton, Michael Biron, Yuli Wang, and Christopher Sims. Provider of invitro platform for drug testing. Altis Biosystems has raised $7.53 million across 15 funding rounds from investors including HHS, NCBiotech and Atlanta Technology Angels. Its chief executive, as recorded, is Michael Biron. Its website altisbiosystems.com draws about 17 thousand monthly visits. Altis Biosystems offers products and services including RepliGut® Kits, Custom InflammaScreen, and StemTox. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Cell Based Assays. Its legal entity is Altis Biosystems, Inc. Its competitors include Aurita Bioscience Corporation and Mabgen; 1 of its 2 listed competitors has raised funding.
Company details
Altis Biosystems was founded in 2015 in Durham, United States, focusing on biotechnology for drug development. A stem cell-derived platform called RepliGut is utilized to assess drug disposition, including toxicity, metabolism, absorption, and efficacy. Operations center on in vitro modeling to support pharmaceutical research, with services aimed at improving drug safety and performance evaluations.
- Headquarters Durham, United States
- Founders Scott Magness, Nancy Allbritton, Michael Biron, Yuli Wang, Christopher Sims
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website altisbiosystems.com
- Social LinkedIn
- Legal Name Altis Biosystems, Inc.
- Total Equity Funding$7.53M (USD)
in 15 rounds
- Latest Funding Round$2.13M (USD), Seed
Mar 2025
- InvestorsHHS
& 7 more
Products & Services of Altis Biosystems
Altis Biosystems offers a comprehensive portfolio of products and services, including RepliGut® Kits, Custom InflammaScreen, and StemTox.
Kits for replicating human intestinal structures in drug testing.
Service to evaluate inflammatory effects on intestinal models.
Assay for predicting gastrointestinal toxicity risks in therapeutics.
Funding Insights of Altis Biosystems
Altis Biosystems has successfully raised a total of $7.53M across 15 strategic funding rounds. The most recent funding activity was a Seed round of $2.13 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.53M
- Total Rounds 15
- Last Round Seed — $2.13M
- Investors Count 8
Latest 10 of 15 funding rounds of Altis Biosystems with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2025 | $2.13M | Seed | – | – | – |
| Sep 2023 | $343,297 | Grant | – | – | |
| Jul 2023 | $1.83M | Grant | – | – | |
| Aug 2022 | $1.36M | Seed | – | – | – |
| Jul 2022 | $256,574 | Grant | – | – | |
| Jun 2022 | $500,000 | Debt – Conventional | – | – | |
| May 2022 | $293,991 | Grant | – | – | |
| May 2022 | $1.98M | Grant | – | – | |
| Jul 2021 | $2.15M | Grant | – | – | |
| Jul 2020 | $3.1M | Seed | – | VentureSouth |
8 investors in total: 8 institutional.
Investors in Altis Biosystems
Altis Biosystems has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, NCBiotech and Atlanta Technology Angels.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biotech startups are incubated and funded in North Carolina. | 1984 | ncbiotech.org | Durham, United States | |
Early-stage ventures in the Southeast are supported by VentureSouth. | 2014 | venturesouth.vc | Greenville, United States | |
Angel investments are provided across Atlanta and Georgia. | 1998 | angelatlanta.com | Atlanta, United States | |
| centraltexasangelnetwork.com | ||||
Tech & Life Sciences focused VC firm investing in early stage companies in the US & Europe | hatterasvp.com | Durham, United States | ||
| rtpcapital.org | ||||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Entrepreneurial potential in North Carolina is supported by NC IDEA. | 2006 | ncidea.org | Durham, United States |
Investor details for Altis Biosystems
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Altis Biosystems
18 people are tracked at Altis Biosystems (7 in leadership, 5 in board & advisors, 6 in team).
| Name | Role | Group |
|---|---|---|
Scott Magness | Co-Founder | Leadership |
Nancy Allbritton | Co-Founder | Leadership |
Michael Biron | Co-Founder & CEO | Leadership |
Yuli Wang | Co-Founder & CSO | Leadership |
Christopher Sims | Co-Founder & President | Leadership |
Liz Boazak | Director, R&d | Leadership |
Maureen Bunger, PhD, MBA | Senior Director Marketing and Product Management | Leadership |
Sue Mahony | Director | Board & advisors |
Ben Scruggs | Director | Board & advisors |
Sam Franklin | Director | Board & advisors |
Joe McMahon | Director | Board & advisors |
Scott Albert | Member Business Advisory Board | Board & advisors |
Reganne Lorichon | Senior Research Associate | Team |
Jarrett Bliton, PhD | Scientific Specialist I | Team |
Earnest Taylor, PhD | Research Scientist | Team |
Napoleon Butler | Research Scientist I - Project Lead | Team |
Lauren Boone | Senior Research Associate | Team |
Stephanie Buchko | Senior Human Resources Manager | Team |
Complete people profiles for Altis Biosystems
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Altis Biosystems
3 dated milestones of Altis Biosystems across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Altis Biosystems is founded.
- Funding First funding round.
- Funding Latest funding round, Seed, of $2.1M.
Competitors of Altis Biosystems
Altis Biosystems has 2 listed competitors in our database, 1 of them funded. They include Aurita Bioscience Corporation and Mabgen.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| auritabio.com | 2021 | Gainesville, United States | $180,491 | Developer of three-dimensional bioscience products and tools for research and clinical settings | ||
| mabgenllc.com | 2004 | Houston, United States | Cytotoxicity screening devices for drug discovery are developed by Mabgen. |
Detailed competitors of Altis Biosystems
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Altis Biosystems
The website of Altis Biosystems (altisbiosystems.com) receives about 16.6K visits a month.
- Monthly visits16.6K
▲ 367.2% vs previous month
Websites whose visitors overlap most with Altis Biosystems. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| catawbaresearch.com | 100% | 3.5K | #5,071,999 | View details | |
| saperebio.com | 97% | View details | |||
| lifeeditinc.com | 95% | View details | |||
| xilis.com | 92% | 2.5K | #6,836,474 | View details | |
| kriyatherapeutics.com | 75% | 8.3K | #2,376,825 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Altis Biosystems
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Altis Biosystems (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Altis Biosystems
Complete news archive for Altis Biosystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Altis Biosystems
Altis Biosystems was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Altis Biosystems is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Michael Biron is the CEO of Altis Biosystems, as recorded in our data. They have also founded this company.
Altis Biosystems is a funded company, having raised a total of $7.53M across 15 funding rounds to date. The company's 1st funding round was a Seed of $3.1M, raised on Nov 2017.
Altis Biosystems was founded in 2015 in Durham, United States, focusing on biotechnology for drug development. A stem cell-derived platform called RepliGut is utilized to assess drug disposition, including toxicity, metabolism, absorption, and efficacy. Operations center on in vitro modeling to support pharmaceutical research, with services aimed at improving drug safety and performance evaluations.
Altis Biosystems's top competitors include Aurita Bioscience Corporation and Mabgen.
Altis Biosystems offers RepliGut® Kits, Custom InflammaScreen, and StemTox.
Altis Biosystems has 8 investors. Key investors include HHS, NCBiotech, Atlanta Technology Angels, VentureSouth, and Central Texas Angel Network.
Altis Biosystems operates through Altis Biosystems, Inc..